Needham & Company LLC reaffirmed their hold rating on shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) in a report released on Wednesday morning, Benzinga reports. A number of other equities research analysts also recently weighed in on AMPH. JPMorgan Chase & Co. began coverage on shares of Amphastar Pharmaceuticals in a research note on […]
Legato Capital Management LLC lifted its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 95.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,217 shares of the company’s stock after purchasing an additional 7,431 […]
StockNews.com cut shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a buy rating to a hold rating in a research report report published on Tuesday. Separately, Bank of America began coverage on Amphastar Pharmaceuticals in a research report on Friday, November 17th. They issued a neutral rating and a $63.00 price objective on the […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) Director Floyd F. Petersen sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $61.37, for a total transaction of $30,685.00. Following the sale, the director now owns 80,833 shares in the […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report)’s stock price shot up 2.4% during trading on Friday . The company traded as high as $65.92 and last traded at $64.99. 97,849 shares were traded during trading, a decline of 76% from the average session volume of 399,794 shares. The stock had previously closed at $63.45. […]